TWI799871B - 三環并環類化合物，其製法與醫藥上的用途 - Google Patents
三環并環類化合物，其製法與醫藥上的用途 Download PDFInfo
- Publication number
- TWI799871B TWI799871B TW110118847A TW110118847A TWI799871B TW I799871 B TWI799871 B TW I799871B TW 110118847 A TW110118847 A TW 110118847A TW 110118847 A TW110118847 A TW 110118847A TW I799871 B TWI799871 B TW I799871B
- Authority
- TW
- Taiwan
- Prior art keywords
- preparation
- medical application
- tricyclic compound
- tricyclic
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010461834 | 2020-05-27 | ||
| CN202010461834.8 | 2020-05-27 | ||
| CN202010956281.3 | 2020-09-11 | ||
| CN202010956281 | 2020-09-11 | ||
| CN202011627054 | 2020-12-30 | ||
| CN202011627054.2 | 2020-12-30 | ||
| CN202110513435.6 | 2021-05-11 | ||
| CN202110513435 | 2021-05-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202204366A TW202204366A (zh) | 2022-02-01 |
| TWI799871B true TWI799871B (zh) | 2023-04-21 |
Family
ID=78745630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110118847A TWI799871B (zh) | 2020-05-27 | 2021-05-25 | 三環并環類化合物，其製法與醫藥上的用途 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230203060A1 (zh) |
| EP (1) | EP4159739A1 (zh) |
| CN (1) | CN115551867B (zh) |
| TW (1) | TWI799871B (zh) |
| WO (1) | WO2021239058A1 (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019217307A1 (en) | 2018-05-07 | 2019-11-14 | Mirati Therapeutics, Inc. | Kras g12c inhibitors |
| EP3908283A4 (en) | 2019-01-10 | 2022-10-12 | Mirati Therapeutics, Inc. | KRAS G12C INHIBITORS |
| JP2022546043A (ja) | 2019-08-29 | 2022-11-02 | ミラティ セラピューティクス， インコーポレイテッド | Ｋｒａｓ ｇ１２ｄ阻害剤 |
| MX2022003537A (es) | 2019-09-24 | 2022-07-11 | Mirati Therapeutics Inc | Terapias de combinacion. |
| MX2022007515A (es) | 2019-12-20 | 2022-09-19 | Mirati Therapeutics Inc | Inhibidores de sos1. |
| CN114539286B (zh) * | 2020-11-24 | 2024-02-02 | 成都百裕制药股份有限公司 | 哌嗪衍生物及其在医药上的应用 |
| WO2022133345A1 (en) | 2020-12-18 | 2022-06-23 | Erasca, Inc. | Tricyclic pyridones and pyrimidones |
| WO2022235870A1 (en) | 2021-05-05 | 2022-11-10 | Revolution Medicines, Inc. | Ras inhibitors for the treatment of cancer |
| WO2022235864A1 (en) | 2021-05-05 | 2022-11-10 | Revolution Medicines, Inc. | Ras inhibitors |
| CN117677398A (zh) | 2021-07-27 | 2024-03-08 | 东丽株式会社 | 用于癌的治疗和/或预防的药品 |
| WO2023114954A1 (en) | 2021-12-17 | 2023-06-22 | Genzyme Corporation | Pyrazolopyrazine compounds as shp2 inhibitors |
| EP4227307A1 (en) | 2022-02-11 | 2023-08-16 | Genzyme Corporation | Pyrazolopyrazine compounds as shp2 inhibitors |
| WO2023172940A1 (en) | 2022-03-08 | 2023-09-14 | Revolution Medicines, Inc. | Methods for treating immune refractory lung cancer |
| WO2023240263A1 (en) | 2022-06-10 | 2023-12-14 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110603258A (zh) * | 2017-05-11 | 2019-12-20 | 阿斯利康(瑞典)有限公司 | 抑制g12c突变型ras蛋白的杂芳基化合物 |
| TW202100532A (zh) * | 2019-03-05 | 2021-01-01 | 瑞典商阿斯特捷利康公司 | 稠合三環化合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090318412A1 (en) * | 2006-07-11 | 2009-12-24 | Takahiro Matsumoto | Tricyclic heterocyclic compound and use thereof |
| TW201938561A (zh) * | 2017-12-08 | 2019-10-01 | 瑞典商阿斯特捷利康公司 | 化學化合物 |
| TW202012415A (zh) * | 2018-05-08 | 2020-04-01 | 瑞典商阿斯特捷利康公司 | 化學化合物 |
-
2021
- 2021-05-25 TW TW110118847A patent/TWI799871B/zh active
- 2021-05-27 US US17/927,961 patent/US20230203060A1/en active Pending
- 2021-05-27 EP EP21813120.9A patent/EP4159739A1/en active Pending
- 2021-05-27 CN CN202180032505.4A patent/CN115551867B/zh active Active
- 2021-05-27 WO PCT/CN2021/096424 patent/WO2021239058A1/zh unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110603258A (zh) * | 2017-05-11 | 2019-12-20 | 阿斯利康(瑞典)有限公司 | 抑制g12c突变型ras蛋白的杂芳基化合物 |
| TW202100532A (zh) * | 2019-03-05 | 2021-01-01 | 瑞典商阿斯特捷利康公司 | 稠合三環化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4159739A1 (en) | 2023-04-05 |
| TW202204366A (zh) | 2022-02-01 |
| WO2021239058A1 (zh) | 2021-12-02 |
| CN115551867B (zh) | 2024-02-20 |
| US20230203060A1 (en) | 2023-06-29 |
| CN115551867A (zh) | 2022-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI799871B (zh) | 三環并環類化合物，其製法與醫藥上的用途 | |
| EP3753941A4 (en) | PYRIMIDINE CONDENSED CYCLIC COMPOUND, METHOD FOR MANUFACTURING IT, AND USE THEREOF | |
| SG11202105850YA (en) | Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof | |
| IL290276A (en) | Tetracyclic compounds, method for its preparation and use | |
| EP3594214A4 (en) | COMPOUND POLYMORPH, RELATED PREPARATION PROCESS AND USE THEREOF | |
| EP3896062A4 (en) | ISOINDOLINE COMPOUND, PROCESS FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION AND USE OF THE ISOINDOLINE COMPOUND | |
| DK3312177T3 (da) | Tricyklisk derivatforbindelse, fremgangsmåde til at fremstille samme og farmaceutisk sammensætning omfattende samme | |
| EP3636646A4 (en) | HETEROARYL PYRAZOL DERIVATIVE AND MANUFACTURING METHOD FOR IT AND MEDICAL USES THEREOF | |
| DK3381469T3 (da) | Anti-erbb2 antistoflægemiddelskonjugat og sammensætning deraf, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| EP3412669A4 (en) | TRICYCLIC COMPOUND FOR PROTEIN INHIBITOR CONTAINING BROMODOMAINE AND PREPARATION, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| EP3967687A4 (en) | SUBSTITUTED PHENYLPROPENYLPYRIDE DERIVATIVE AND METHOD OF MANUFACTURE THEREOF AND MEDICAL USE THEREOF | |
| EP3424924A4 (en) | UREA CONNECTION, MANUFACTURING METHOD AND MEDICAL USE THEREOF | |
| EP3564253A4 (en) | ANTIDEPRESSIVE PREPARATION AND PRODUCTION METHOD AND USE THEREOF | |
| EP3822271A4 (en) | PYRIDOPYRIMIDI DERIVATIVE, METHOD OF MANUFACTURE THEREOF AND MEDICAL USE THEREOF | |
| EP3406602A4 (en) | 1-SULFONAMIDO-4-ARYLOXY COMPOUND, PREPARATION METHOD AND MEDICINAL APPLICATION | |
| EP3321284A4 (en) | Monoclonal antibody of human procalcitonin, preparation method therefor, and application thereof | |
| EP3556761A4 (en) | PYRROLO-AROMATIC HETEROCYCLIC COMPOUND, PRODUCTION METHOD THEREFOR, AND MEDICAL USE THEREOF | |
| DK3744316T3 (da) | Oftalmisk farmaceutisk sammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| EP4063363A4 (en) | PYRAZOLE HETEROARYL DERIVATIVE, PROCESS THEREOF AND MEDICAL USE THEREOF | |
| EP4249480A4 (en) | DIPHENYLPYRAZOLE COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF | |
| IL289416A (en) | Tricyclic compound, its preparation method and use | |
| EP4023659A4 (en) | COMPOUND AND DRUG CONJUGATE, PRODUCTION METHOD AND USE THEREOF | |
| EP4056551A4 (en) | CRYSTAL FORM I OF A CURCUMIN DERIVATIVE, PRODUCTION PROCESS THEREOF AND USE THEREOF | |
| EP3730484A4 (en) | INDOLEAMINE-2,3-DIOXYGENASE INHIBITOR, PROCESS FOR PREPARATION AND APPLICATION | |
| IL282817A (en) | New material, production method, and its use |